Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Califf Nomination Hearing Expected Before Holiday Season

This article was originally published in The Tan Sheet

Executive Summary

The Senate HELP Committee has competing priorities, but the FDA commissioner nominee still seems to have smooth path to confirmation.

You may also be interested in...



Califf Nomination May Show Confidence In His Bipartisan Appeal

After seven months as deputy commissioner for medical products and tobacco, Robert Califf tapped to be FDA Commissioner.

Oral History Of Drug Development: FDA’s Califf Wants Woodcock, Temple To Share Their Stories

In an interview with “The Pink Sheet,” new deputy commissioner for medical products says FDA needs better ways of helping stakeholders, public understand agency thinking.

Senate Passes User Fee Package With Ease

Sanders casts the lone dissenting vote, saying it does not do enough to curb drug costs. Pay-for-delay and drug reimportation amendments fail.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS107942

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel